EUVIMEDObjevte EUVIMED
Crossref

Medicarpin suppresses proliferation and triggeres apoptosis by upregulation of BID , BAX , CASP3 , CASP8 , and CYCS in glioblastoma

Lu Ying, Mingxuan Hao, Zichen Zhang, Rui Guo, Youfeng Liang, Changyuan Yu, Zhao Yang

Chemical Biology & Drug Design · 2023-11 · 102 (5) · 1097-1109

DOI: 10.1111/cbdd.14309 ↗

At a glance

Journal article in Chemical Biology & Drug Design, published online on 2023-07-28. Written by Lu Ying and 6 co-authors. Institution: College of Life Science and Technology, Innovation Center of Molecular Diagnostics, Beijing University of Chemical Technology, Beijing, China. Major MEDLINE topics: Brain Neoplasms, Glioblastoma. Cited 22 times so far (Crossref); 45 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Glioblastoma (GBM) is the most malignant brain tumor and incurable. Medicarpin (MED), a flavonoid compound from the legume family, has multiple targets and anticancer properties. However, the role of MED in GBM remains unclear. The objective of this study was to explore the effects of MED on the apoptosis of GBM and to explain the potential molecular mechanisms. We found that the IC 50 values of U251 and U‐87 MG cells treated with MED for 24 h were 271 μg/mL and 175 μg/mL, and the IC 50 values for 48 h were 154 μg/mL and 161 μg/mL, respectively. Additionally, the cell cycle of U251 and U‐87 MG cells were arrested at the G2/M phase. Furthermore, the apoptosis rate of U251 and U‐87 MG cells increased from 6.26% to 18.36% and 12.46% to 31.33% for 48 h, respectively. The migration rate of U251 and U‐87 MG decreased from 20% to 5% and 25% to 15% for 12 h and these of U251 and U‐87 MG decreased from 50% to 28% and 60% to 25% for 24 h. MED suppressed GBM tumorigenesis, and improved survival rate of tumor‐bearing mice. Taken together, MED triggered GBM apoptosis through upregulation of pro‐apoptotic proteins (BID, BAX, CASP3, CASP8, and CYCS), showed strong inhibitory effects on cell proliferation and cell migration, and displayed anti‐tumor activity in nude mice.

Subjects

MeSH terms (MEDLINE)

Brain NeoplasmsGlioblastomaAnimalsMiceApoptosisbcl-2-Associated X ProteinCaspase 3Cell Line, TumorCell ProliferationMice, NudeUp-RegulationCaspase 8PterocarpansPhytoalexinsBH3 Interacting Domain Death Agonist Protein

Author keywords

apoptosisglioblastomamedicarpinproliferationxenograft tumor model

Substances

bcl-2-Associated X ProteinCaspase 3Caspase 8medicarpinPterocarpansPhytoalexinsBid protein, mouseBH3 Interacting Domain Death Agonist Protein

Authors and institutions

  • College of Life Science and Technology, Innovation Center of Molecular Diagnostics, Beijing University of Chemical Technology, Beijing, China.
  • College of Life Science and Technology, Key Laboratory of Protection and Utilization of Biological Resources in Tarim Basin of Xinjiang Production and Construction Corps, Tarim University, Xinjiang, China.

Cite

APA

Ying, L., Hao, M., Zhang, Z., Guo, R., Liang, Y., Yu, C., & Yang, Z. (2023). Medicarpin suppresses proliferation and triggeres apoptosis by upregulation of BID , BAX , CASP3 , CASP8 , and CYCS in glioblastoma. Chemical Biology & Drug Design, 102(5), 1097-1109. https://doi.org/10.1111/cbdd.14309

Vancouver

Ying L, Hao M, Zhang Z, Guo R, Liang Y, Yu C, et al. Medicarpin suppresses proliferation and triggeres apoptosis by upregulation of BID , BAX , CASP3 , CASP8 , and CYCS in glioblastoma. Chemical Biology & Drug Design. 2023;102(5):1097-1109. doi:10.1111/cbdd.14309

BibTeX
@article{Ying2023,
  author = {Ying, Lu and Hao, Mingxuan and Zhang, Zichen and Guo, Rui and Liang, Youfeng and Yu, Changyuan and Yang, Zhao},
  title = {Medicarpin suppresses proliferation and triggeres apoptosis by upregulation of BID , BAX , CASP3 , CASP8 , and CYCS in glioblastoma},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  volume = {102},
  number = {5},
  pages = {1097--1109},
  doi = {10.1111/cbdd.14309}
}
Start for free →